Burning Rock Biotech Limited
BNR
$22.01
-$0.74-3.25%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -33.07M | -48.14M | -48.14M | -59.31M |
| Total Depreciation and Amortization | -- | 7.14M | 7.14M | 7.14M | 18.21M |
| Total Amortization of Deferred Charges | -- | 113.00K | 113.00K | 113.00K | 269.80K |
| Total Other Non-Cash Items | -- | 20.44M | 33.15M | 33.15M | 30.37M |
| Change in Net Operating Assets | -- | -5.08M | -5.08M | -5.08M | -7.22M |
| Cash from Operations | -- | -10.45M | -12.82M | -12.82M | -17.69M |
| Capital Expenditure | -- | -753.30K | -753.30K | -753.30K | -1.12M |
| Sale of Property, Plant, and Equipment | -- | 217.60K | 217.60K | 217.60K | 11.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 43.20K | -78.60K | -78.60K | 563.80K |
| Cash from Investing | -- | -492.60K | -614.40K | -614.40K | -546.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -72.00K | -72.00K | -72.00K | -6.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | 5.07M |
| Cash from Financing | -- | -10.00K | -10.00K | -10.00K | -264.10K |
| Foreign Exchange rate Adjustments | -- | 543.50K | 509.40K | 509.40K | -742.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -10.41M | -12.93M | -12.93M | -19.24M |